Growth Metrics

Inogen (INGN) EBT Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.50%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.26%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -8.83%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 5.78%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 103.34%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 74.66%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.02%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 54.33%
10 Inogen 165.85 Mn 71.44 Mn 37.86 Mn -35.51%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -35.51%
Dec 31, 2025 -167.36%
Sep 30, 2025 10.29%
Jun 30, 2025 23.08%
Mar 31, 2025 57.42%
Dec 31, 2024 89.83%
Sep 30, 2024 86.62%
Jun 30, 2024 42.80%
Mar 31, 2024 26.92%
Dec 31, 2023 -196.91%
Sep 30, 2023 -380.27%
Jun 30, 2023 -190.10%
Mar 31, 2023 -44.05%
Dec 31, 2022 292.65%
Sep 30, 2022 -259.15%
Jun 30, 2022 -128.10%
Mar 31, 2022 -486.58%
Dec 31, 2021 -178.77%
Sep 30, 2021 409.93%
Jun 30, 2021 240.54%
Mar 31, 2021 -41.38%
Dec 31, 2020 -22.85%
Sep 30, 2020 -121.86%
Jun 30, 2020 -74.24%
Mar 31, 2020 -127.78%
Dec 31, 2019 -172.76%
Sep 30, 2019 -22.53%
Jun 30, 2019 0.28%
Mar 31, 2019 -37.32%
Dec 31, 2018 0.50%
Sep 30, 2018 28.15%
Jun 30, 2018 48.88%
Mar 31, 2018 64.77%
Dec 31, 2017 -0.69%
Sep 30, 2017 61.81%
Jun 30, 2017 13.98%
Mar 31, 2017 72.91%
Dec 31, 2016 75.88%
Sep 30, 2016 48.15%
Jun 30, 2016 51.34%
Mar 31, 2016 40.61%
Dec 31, 2015 148.09%
Sep 30, 2015 5.87%
Jun 30, 2015 40.73%
Mar 31, 2015 65.05%
Dec 31, 2014 473.82%
Sep 30, 2014 325.21%
Jun 30, 2014 85.37%
Mar 31, 2014 92.51%